What is Zacks Research’s Estimate for EMN FY2025 Earnings?

Eastman Chemical Company (NYSE:EMN) – Equities research analysts at Zacks Research reduced their FY2025 earnings per share (EPS) estimates for Eastman Chemical in a research note issued to investors on Friday, November 14th. Zacks Research analyst Team now anticipates that the basic materials company will earn $5.54 per share for the year, down from their previous forecast of $6.07. The consensus estimate for Eastman Chemical’s current full-year earnings is $8.55 per share. Zacks Research also issued estimates for Eastman Chemical’s Q1 2027 earnings at $1.75 EPS, Q2 2027 earnings at $1.75 EPS and Q3 2027 earnings at $1.89 EPS.

Several other equities analysts have also issued reports on the stock. Evercore ISI dropped their target price on shares of Eastman Chemical from $75.00 to $70.00 and set an “in-line” rating on the stock in a report on Tuesday, November 11th. Citigroup lifted their price objective on Eastman Chemical from $68.00 to $70.00 and gave the stock a “buy” rating in a research report on Thursday, October 2nd. KeyCorp set a $79.00 target price on Eastman Chemical and gave the company an “overweight” rating in a research report on Monday, August 4th. Bank of America lowered their target price on Eastman Chemical from $78.00 to $74.00 and set a “buy” rating for the company in a report on Tuesday, October 14th. Finally, UBS Group dropped their price target on Eastman Chemical from $75.00 to $73.00 and set a “buy” rating on the stock in a research note on Wednesday, November 5th. Eight equities research analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the company’s stock. According to MarketBeat.com, Eastman Chemical presently has an average rating of “Moderate Buy” and a consensus price target of $78.62.

Eastman Chemical Stock Performance

NYSE:EMN opened at $57.58 on Monday. The company has a debt-to-equity ratio of 0.81, a quick ratio of 0.78 and a current ratio of 1.68. Eastman Chemical has a fifty-two week low of $56.72 and a fifty-two week high of $107.50. The company has a 50 day simple moving average of $62.23 and a two-hundred day simple moving average of $70.33. The company has a market capitalization of $6.57 billion, a PE ratio of 8.09, a P/E/G ratio of 6.16 and a beta of 1.31.

Eastman Chemical (NYSE:EMN) last issued its quarterly earnings results on Monday, November 3rd. The basic materials company reported $1.14 EPS for the quarter, missing analysts’ consensus estimates of $1.18 by ($0.04). The business had revenue of $2.20 billion for the quarter, compared to analyst estimates of $2.28 billion. Eastman Chemical had a return on equity of 15.24% and a net margin of 8.96%.Eastman Chemical’s revenue for the quarter was down 10.6% on a year-over-year basis. During the same quarter last year, the firm posted $2.26 EPS. Eastman Chemical has set its FY 2025 guidance at 5.400-5.65 EPS.

Hedge Funds Weigh In On Eastman Chemical

Hedge funds have recently bought and sold shares of the company. Norges Bank purchased a new position in Eastman Chemical in the second quarter valued at approximately $121,060,000. State Street Corp lifted its position in shares of Eastman Chemical by 24.3% during the 3rd quarter. State Street Corp now owns 5,687,097 shares of the basic materials company’s stock valued at $363,314,000 after buying an additional 1,112,391 shares during the last quarter. Allspring Global Investments Holdings LLC grew its stake in shares of Eastman Chemical by 1,011.5% during the 3rd quarter. Allspring Global Investments Holdings LLC now owns 943,975 shares of the basic materials company’s stock worth $58,489,000 after acquiring an additional 859,046 shares during the period. Qube Research & Technologies Ltd increased its holdings in Eastman Chemical by 1,456.4% in the 2nd quarter. Qube Research & Technologies Ltd now owns 708,290 shares of the basic materials company’s stock worth $52,881,000 after acquiring an additional 662,783 shares during the last quarter. Finally, Arrowstreet Capital Limited Partnership raised its stake in Eastman Chemical by 576.0% in the 3rd quarter. Arrowstreet Capital Limited Partnership now owns 707,304 shares of the basic materials company’s stock valued at $44,596,000 after acquiring an additional 602,677 shares during the period. 83.65% of the stock is owned by hedge funds and other institutional investors.

About Eastman Chemical

Eastman Chemical Company operates as a specialty materials company in the United States, China, and internationally. The company's Additives & Functional Products segment offers amine derivative-based building blocks, intermediates for surfactants, metam-based soil fumigants, and organic acid-based solutions; specialty coalescent and solvents, paint additives, and specialty polymers; and heat transfer and aviation fluids.